Amgen Study Comparing UV-C Exposure versus Oxidation Levels and Activity Trends
| Peptide Mapping Results | |||
|---|---|---|---|
| Control (0 mJ) | Low (∼15 mJ) | Medium (∼150 mJ) | |
| Met-249 | 2.4% | 2.9% | 6.8% |
| Met-425 | 1.1% | 1.4% | 4.2% |
| In-vitro BioActivity | |||
| Sample ID | % Relative Potency | ||
| Control (0 mJ) | 86 | ||
| Control (125 mJ) | 86 | ||
| Control (375 mJ) | 86 | ||
| Control w/ Add 1 (0 mJ) | 89 | ||
| Control w/ Add 1 (125 mJ) | 87 | ||
| Control w/ Add 1 (375 mJ) | 89 | ||